Wordt geladen...
New Schizophrenia Treatments Address Unmet Clinical Needs
We present several novel drugs in development for enhancing cognition, treating negative symptoms, and providing improved options for treatment-resistant patients. Drug makers aim to enhance safety profiles and increase patient compliance to therapy.
Bewaard in:
| Gepubliceerd in: | P T |
|---|---|
| Hoofdauteur: | |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MediMedia USA, Inc.
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5265239/ https://ncbi.nlm.nih.gov/pubmed/28163559 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|